Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program
نویسندگان
چکیده
منابع مشابه
Post-Marketing Safety Surveillance of the Salvia Miltiorrhiza Depside Salt for Infusion: A Real World Study
BACKGROUND Salvia Miltiorrhiza Depside Salt for Infusion (SMDS) is made of a group of highly purified listed drugs. However, its safety data is still reported limitedly. Compared with the clinical trials, its safety in the real world setting is barely assessed. OBJECTIVE To investigate the safety issues, including adverse events (AEs), adverse events related to SMDS (ADEs), and adverse drug r...
متن کاملHeadache (chronic tension-type).
INTRODUCTION Chronic tension-type headache (CTTH) is a disorder that evolves from episodic tension-type headache, with daily, or very frequent, episodes of headache lasting hours or they may be continuous. It affects up to 4% of the general population, and is more prevalent in women (up to 65% of cases). METHODS AND OUTCOMES We conducted a systematic overview, aiming to answer the following c...
متن کاملSafety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
BACKGROUND AND PURPOSE Zonisamide (ZNS) is one of new antiepileptic drug, which is known to inhibit seizure through multiple mechanisms of action. In Korea, ZNS was approved as an antiepileptic drug in 1992 and has been used for epilepsy patients with partial and generalized seizures. The objective of this study was to investigate the efficacy and tolerability of ZNS in patients with epilepsy a...
متن کاملChronic tension-type headache: where are we?
Primary headache syndromes may generally be distinguished as being either episodic, such as typical migraine or cluster headache, or chronic, such as chronic tension-type headache (CTTH) or hemicrania continua. In truth it is chronic headache, and most particularly chronic daily headache (CDH) in its various forms, that gives the sub-speciality of headache a bad name. Daily headache in all its ...
متن کاملPost marketing surveillance on safety and efficacy of IMOD in Iranian patients with HIV/AIDS.
Acquired immune deficiency syndrome is one of the world's serious health problems. Immune-based therapy is a new approach in the treatment of HIV infected patients. IMOD™ with the ability to correct immune deficiencies has been introduced for the management of HIV infection. In the phase IV trial study the main objectives were to assess the possible side effects, evaluate its effect on CD4⁺ T l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pain and Therapy
سال: 2020
ISSN: 2193-8237,2193-651X
DOI: 10.1007/s40122-020-00207-y